AK Medical Holdings Limited (1789.HK)

HKD 5.17

(3.4%)

EBITDA Summary of AK Medical Holdings Limited

  • AK Medical Holdings Limited's latest annual EBITDA in 2023 was 323.34 Million CNY , up 0.15% from previous year.
  • AK Medical Holdings Limited's latest quarterly EBITDA in 2024 Q2 was 162.09 Million HKD , down 0.0% from previous quarter.
  • AK Medical Holdings Limited reported an annual EBITDA of 322.86 Million CNY in 2022, up 75.16% from previous year.
  • AK Medical Holdings Limited reported an annual EBITDA of 184.32 Million CNY in 2021, down -57.96% from previous year.
  • AK Medical Holdings Limited reported a quarterly EBITDA of 211.46 Million HKD for 2023 Q2, down 0.0% from previous quarter.
  • AK Medical Holdings Limited reported a quarterly EBITDA of 96.23 Million HKD for 2023 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of AK Medical Holdings Limited (2023 - 2014)

Historical Annual EBITDA of AK Medical Holdings Limited (2023 - 2014)

Year EBITDA EBITDA Growth
2023 323.34 Million CNY 0.15%
2022 322.86 Million CNY 75.16%
2021 184.32 Million CNY -57.96%
2020 438.41 Million CNY 28.42%
2019 341.38 Million CNY 77.83%
2018 195.25 Million CNY 39.99%
2017 137.12 Million CNY 34.25%
2016 101.69 Million CNY 30.87%
2015 77.89 Million CNY 25.25%
2014 62.23 Million CNY 0.0%

Peer EBITDA Comparison of AK Medical Holdings Limited

Name EBITDA EBITDA Difference
Vincent Medical Holdings Limited 104.43 Million HKD -209.621%